Pure red cell aplasia (PRCA) and Evans syndrome following allogeneic hematopoietic stem cell transplantation (HSCT) from a blood type-matched donor are very rare. A 29-year-old Japanese woman with hematologic remission of Philadelphia chromosomepositive acute lymphoblastic leukemia underwent bone marrow transplantation from a blood type-matched, HLA 6/6 matched, unrelated donor in May 2008. Her clinical course after transplantation was favorable, and allowed for a gradual reduction in tacrolimus dosage. However, 12 months after transplantation, she developed PRCA related to allogeneic HSCT. The patient s PRCA was alleviated by stopping the dosage reduction for the immunosuppressive therapy and by continued administration of lowdose tacrolimus. Three months after the PRCA diagnosis, the patient developed Evans syndrome, so prednisolone (PSL) treatment was initiated. PSL treatment effectively treated the Evans syndrome, as was evident by the absence of cythemolysis two months later, and no relapse has occurred even after the PSL dose was reduced and then terminated. The fact that PRCA onset in this case occurred after blood type-matched allogeneic HSCT, during the late grafting phase, and in combination with Evans syndrome, suggests that the pathogenic mechanism may differ from that of previously reported cases of PRCA following blood type-incompatible allogeneic HSCT. (Journal of Hematopoietic Cell Transplantation Vol. 1 No. 1; 24-28, 2012) 
Background
Pure red cell aplasia (PRCA) and autoimmune hemolytic anemia (AIHA) are rare complications that follow allogeneic hematopoietic stem cell transplantation (HSCT) [1 3] . PRCA has occurred after blood type-mismatched allogeneic HSCT, in which case the remaining isohemagglutinin in the recipient plasma is thought to suppress erythropoiesis [4] . With regard to AIHA, continuous suppression of cellular immunity after allogeneic HSCT is thought to affect humoral immunity, yielding the production of autoantibodies which contribute to hemolysis [2, 5, 6] . Here we report a case of PRCA followed by Evans syndrome that developed after unrelated donor allogeneic HSCT from a blood type-matched, human leukocyte antigen (HLA) 6/6 matched donor.
Case Report
The patient was a 29 year-old Japanese woman without remarkable medical or family histories. 
Discussion
We report our experiences with a 29-year-old Japanese female patient who presented with PRCA and Evans syndrome following HSCT from a blood type-matched, HLA6/6 matched unrelated donor. Most reported cases of PRCA following allogeneic HSCT are attributed to blood type-mismatched donors (major mismatch in particular), and cases of PRCA after transplantation from a blood typematched donor are very rare [1, 4, 6] . On the other hand, AIHA after allogeneic HSCT was reported to occur in 4.5%
of adult cases and as risk factors, unrelated donors, HLAmismatches, and chronic GVHD were pointed out [2, 3] .
Few cases of Evans syndrome after HSCT have been reported. One patient received a HSCT from a T-celldepleted unrelated donor [7] , and another patient was treated with a conditioning regimen of antithymocyte globulin (ATG), which could have over-suppressed T cells, leading to abnormalities in humoral immunity [8] . Some reports have noted a combination of PRCA with AIHA or Evans syndrome in patients with malignant lymphoma [9] and after allogeneic HSCT [6] . To our knowledge, no one has reported a case of PRCA and Evans syndrome following HSCT. However, a combination of PRCA with AIHA or Evans syndrome has been observed in 7 of 357 cases (2.0%) of pancreas transplantation using immunosuppression with alemtuzumab, mycophenolate mofetil, and daclizumab [10] . One factor that may be involved in AIHA and Evans syndrome as well as PRCA is an immune abnormality brought about by excessive immunosuppression, but the causative mechanisms of this remain largely unknown.
The case study did not use drugs such as ATG for the 
